Risk of Secondary ADHD Higher After Childhood TBI

Share this content:
Risk of Secondary ADHD Higher After Childhood TBI
Risk of Secondary ADHD Higher After Childhood TBI

MONDAY, March 19, 2018 (HealthDay News) -- Children with early childhood traumatic brain injury (TBI) have increased risk of secondary attention-deficit/hyperactivity disorder (SADHD), according to a study published online March 19 in JAMA Pediatrics.

Megan E. Narad, Ph.D., from the Cincinnati Children's Hospital Medical Center, and colleagues examined development of SADHD during the five to 10 years after TBI in a cohort of children aged 3 to 7 years hospitalized overnight for TBI or orthopedic injury (OI; used as a control group). Assessments were completed at zero to three months (baseline), six, 12, and 18 months, and 3.4 and 6.8 years after injury in 81 children and adolescents in the TBI group and 106 in the OI group.

The researchers found that 25.7 percent of the 187 children met the definition of SADHD. Compared with the OI group, severe TBI correlated with SADHD (hazard ratio [HR], 3.62; 95 percent confidence interval [CI], 1.59 to 8.26). There was a correlation for higher levels of maternal education with lower risk of SADHD (HR, 0.33; 95 percent CI, 0.17 to 0.62). Within the TBI group, familial dysfunction was associated with increased risk of SADHD (HR, 4.24; 95 percent CI, 1.91 to 9.43), with minimal associations for the OI group (HR, 1.32; 95 percent CI, 0.36 to 4.91).

"Early childhood TBI was associated with increased risk for SADHD. This finding supports the need for postinjury monitoring for attention problems," the authors write. "Consideration of factors that may interact with injury characteristics, such as family functioning, will be important in planning clinical follow-up of children with TBI."

One author disclosed financial ties to the medical technology industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »